Tzu Phang
Concepts (329)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, Glucocorticoid | 4 | 2017 | 136 | 0.500 |
Why?
| Software | 5 | 2013 | 631 | 0.490 |
Why?
| Gene Expression Profiling | 15 | 2014 | 1625 | 0.490 |
Why?
| Databases, Genetic | 3 | 2009 | 257 | 0.410 |
Why?
| Gene Expression Regulation | 9 | 2017 | 2491 | 0.400 |
Why?
| Mammary Glands, Animal | 3 | 2006 | 123 | 0.340 |
Why?
| Chorionic Gonadotropin | 5 | 2000 | 81 | 0.330 |
Why?
| Alternative Splicing | 1 | 2009 | 197 | 0.320 |
Why?
| Receptors, LH | 4 | 2000 | 9 | 0.300 |
Why?
| Nuclear Proteins | 3 | 2017 | 618 | 0.290 |
Why?
| Kruppel-Like Transcription Factors | 2 | 2017 | 57 | 0.280 |
Why?
| Oligonucleotide Array Sequence Analysis | 12 | 2014 | 783 | 0.270 |
Why?
| Computational Biology | 4 | 2013 | 601 | 0.240 |
Why?
| Face | 3 | 2017 | 179 | 0.240 |
Why?
| Lymphoma, Non-Hodgkin | 1 | 2022 | 73 | 0.210 |
Why?
| Dog Diseases | 2 | 2012 | 45 | 0.190 |
Why?
| Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 243 | 0.190 |
Why?
| Precancerous Conditions | 1 | 2021 | 164 | 0.180 |
Why?
| Hemangiosarcoma | 2 | 2010 | 20 | 0.180 |
Why?
| Precision Medicine | 1 | 2024 | 371 | 0.180 |
Why?
| Hermanski-Pudlak Syndrome | 1 | 2019 | 2 | 0.180 |
Why?
| Respiratory System | 2 | 2017 | 144 | 0.170 |
Why?
| Guanine Nucleotide Exchange Factors | 1 | 2019 | 61 | 0.170 |
Why?
| Systems Biology | 2 | 2017 | 59 | 0.170 |
Why?
| Pulmonary Alveoli | 2 | 2012 | 395 | 0.170 |
Why?
| Gene Expression Regulation, Developmental | 2 | 2017 | 852 | 0.160 |
Why?
| Database Management Systems | 2 | 2009 | 57 | 0.160 |
Why?
| Gene Expression Regulation, Neoplastic | 4 | 2012 | 1183 | 0.160 |
Why?
| Phospholipase C delta | 1 | 2017 | 2 | 0.160 |
Why?
| Airway Remodeling | 1 | 2017 | 58 | 0.150 |
Why?
| Proteins | 3 | 2000 | 953 | 0.150 |
Why?
| Maxillofacial Development | 1 | 2017 | 24 | 0.150 |
Why?
| Ectoderm | 1 | 2017 | 47 | 0.150 |
Why?
| Muscle, Smooth | 1 | 2017 | 159 | 0.150 |
Why?
| Pulmonary Fibrosis | 1 | 2019 | 305 | 0.140 |
Why?
| Mesoderm | 1 | 2017 | 148 | 0.140 |
Why?
| Cluster Analysis | 4 | 2010 | 493 | 0.140 |
Why?
| Photoaffinity Labels | 3 | 2000 | 5 | 0.140 |
Why?
| Transcription Factor RelA | 1 | 2016 | 82 | 0.140 |
Why?
| DNA Copy Number Variations | 2 | 2021 | 167 | 0.140 |
Why?
| Saccharopine Dehydrogenases | 1 | 2015 | 2 | 0.140 |
Why?
| Proline Oxidase | 1 | 2015 | 3 | 0.140 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 1996 | 336 | 0.130 |
Why?
| Chromatin Immunoprecipitation | 2 | 2017 | 139 | 0.130 |
Why?
| Response Elements | 1 | 2015 | 85 | 0.130 |
Why?
| Dogs | 3 | 2012 | 382 | 0.130 |
Why?
| Gene Expression | 3 | 2016 | 1506 | 0.130 |
Why?
| Fibroblast Growth Factor 8 | 1 | 2014 | 27 | 0.130 |
Why?
| Cleft Lip | 1 | 2014 | 37 | 0.120 |
Why?
| Transcription Factor AP-2 | 1 | 2014 | 84 | 0.120 |
Why?
| Lung Neoplasms | 2 | 2021 | 2216 | 0.120 |
Why?
| Cleft Palate | 1 | 2014 | 53 | 0.120 |
Why?
| DNA-Binding Proteins | 2 | 2014 | 1384 | 0.120 |
Why?
| Gene Dosage | 1 | 2014 | 139 | 0.120 |
Why?
| Lactation | 2 | 2006 | 162 | 0.120 |
Why?
| Gene Regulatory Networks | 3 | 2013 | 244 | 0.120 |
Why?
| Transcription, Genetic | 3 | 2015 | 1355 | 0.120 |
Why?
| Internet | 2 | 2009 | 686 | 0.120 |
Why?
| Introns | 1 | 2014 | 236 | 0.110 |
Why?
| Cell Line | 6 | 2016 | 2785 | 0.110 |
Why?
| Epithelial Cells | 2 | 2016 | 995 | 0.110 |
Why?
| Antiporters | 2 | 2003 | 19 | 0.110 |
Why?
| Membrane Proteins | 1 | 2019 | 1093 | 0.110 |
Why?
| Lymphoma, T-Cell | 1 | 2012 | 22 | 0.110 |
Why?
| Mice | 12 | 2021 | 15888 | 0.110 |
Why?
| NF-kappa B | 2 | 2014 | 676 | 0.110 |
Why?
| Anti-Inflammatory Agents | 1 | 2016 | 469 | 0.110 |
Why?
| Growth Hormone-Secreting Pituitary Adenoma | 1 | 2012 | 11 | 0.110 |
Why?
| Iodine Radioisotopes | 5 | 2000 | 128 | 0.110 |
Why?
| Lymphoma, B-Cell | 1 | 2012 | 90 | 0.100 |
Why?
| Animals | 17 | 2021 | 34133 | 0.100 |
Why?
| Transcriptome | 2 | 2017 | 774 | 0.100 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2014 | 432 | 0.100 |
Why?
| Immunity, Innate | 3 | 2012 | 762 | 0.100 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2016 | 1003 | 0.100 |
Why?
| Databases, Nucleic Acid | 1 | 2010 | 35 | 0.100 |
Why?
| Comparative Genomic Hybridization | 1 | 2010 | 28 | 0.100 |
Why?
| Philadelphia Chromosome | 1 | 2010 | 15 | 0.100 |
Why?
| Genomics | 2 | 2024 | 714 | 0.100 |
Why?
| Influenza A Virus, H1N1 Subtype | 1 | 2012 | 147 | 0.090 |
Why?
| Fusion Proteins, bcr-abl | 1 | 2010 | 61 | 0.090 |
Why?
| Adenoma | 1 | 2012 | 196 | 0.090 |
Why?
| NFATC Transcription Factors | 1 | 2010 | 83 | 0.090 |
Why?
| Dexamethasone | 3 | 2017 | 323 | 0.090 |
Why?
| Reoviridae | 1 | 2010 | 38 | 0.090 |
Why?
| Influenza A virus | 1 | 2011 | 112 | 0.090 |
Why?
| Down-Regulation | 2 | 2010 | 654 | 0.090 |
Why?
| Humans | 28 | 2024 | 122796 | 0.090 |
Why?
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2010 | 93 | 0.090 |
Why?
| Encephalitis, Viral | 1 | 2010 | 44 | 0.090 |
Why?
| Reoviridae Infections | 1 | 2010 | 55 | 0.090 |
Why?
| Alcohol-Related Disorders | 1 | 2010 | 116 | 0.090 |
Why?
| Breeding | 1 | 2009 | 57 | 0.090 |
Why?
| Wnt Proteins | 1 | 2010 | 144 | 0.090 |
Why?
| Algorithms | 2 | 2009 | 1593 | 0.080 |
Why?
| Neovascularization, Pathologic | 1 | 2010 | 292 | 0.080 |
Why?
| Biomarkers, Tumor | 2 | 2012 | 1076 | 0.080 |
Why?
| RNA Polymerase II | 3 | 2017 | 291 | 0.080 |
Why?
| Estrogen Receptor alpha | 1 | 2009 | 126 | 0.080 |
Why?
| Sequence Analysis, DNA | 1 | 2011 | 766 | 0.080 |
Why?
| Macrophages, Alveolar | 1 | 2010 | 364 | 0.080 |
Why?
| Blood Platelets | 1 | 2010 | 369 | 0.080 |
Why?
| Data Collection | 1 | 2010 | 667 | 0.080 |
Why?
| Pregnenolone Carbonitrile | 1 | 2006 | 3 | 0.070 |
Why?
| Bacterial Proteins | 2 | 2003 | 775 | 0.070 |
Why?
| Sleep | 1 | 2013 | 722 | 0.070 |
Why?
| Receptors, Steroid | 1 | 2006 | 54 | 0.070 |
Why?
| Molecular Sequence Data | 4 | 2015 | 2933 | 0.070 |
Why?
| Models, Statistical | 1 | 2010 | 651 | 0.070 |
Why?
| Influenza, Human | 1 | 2012 | 566 | 0.070 |
Why?
| Up-Regulation | 2 | 2006 | 891 | 0.070 |
Why?
| Neoadjuvant Therapy | 1 | 2008 | 348 | 0.070 |
Why?
| Inflammation | 2 | 2014 | 2598 | 0.070 |
Why?
| Tumor Necrosis Factor alpha-Induced Protein 3 | 2 | 2016 | 7 | 0.070 |
Why?
| Cell Nucleus | 1 | 2008 | 598 | 0.070 |
Why?
| Saccharomyces cerevisiae Proteins | 1 | 2008 | 354 | 0.060 |
Why?
| RNA, Messenger | 6 | 2010 | 2720 | 0.060 |
Why?
| Macrophages | 1 | 2012 | 1334 | 0.060 |
Why?
| Mice, Inbred C57BL | 4 | 2021 | 5020 | 0.060 |
Why?
| Saccharomyces cerevisiae | 1 | 2008 | 507 | 0.060 |
Why?
| Lung | 2 | 2010 | 3830 | 0.060 |
Why?
| Protein Binding | 3 | 2016 | 2010 | 0.060 |
Why?
| Mutagenesis | 3 | 2002 | 185 | 0.060 |
Why?
| Alcoholism | 1 | 2010 | 725 | 0.060 |
Why?
| Calcium | 1 | 2010 | 1244 | 0.060 |
Why?
| Transcription Factors | 2 | 2009 | 1616 | 0.060 |
Why?
| Signal Transduction | 6 | 2015 | 4902 | 0.060 |
Why?
| Models, Biological | 3 | 2012 | 1756 | 0.060 |
Why?
| Lipid Metabolism | 1 | 2006 | 482 | 0.060 |
Why?
| Hemangioma, Cavernous | 1 | 2003 | 16 | 0.060 |
Why?
| Female | 14 | 2021 | 63629 | 0.060 |
Why?
| Pregnancy, Animal | 1 | 2003 | 58 | 0.060 |
Why?
| Biological Specimen Banks | 1 | 2024 | 107 | 0.060 |
Why?
| Tetracycline Resistance | 1 | 2002 | 6 | 0.060 |
Why?
| Sequence Analysis, RNA | 2 | 2017 | 420 | 0.060 |
Why?
| Cell Membrane | 2 | 2006 | 741 | 0.060 |
Why?
| Mitochondria | 1 | 2008 | 809 | 0.050 |
Why?
| HLA-A Antigens | 1 | 2022 | 52 | 0.050 |
Why?
| Cells, Cultured | 4 | 2017 | 4162 | 0.050 |
Why?
| Intracranial Arteriovenous Malformations | 1 | 2003 | 53 | 0.050 |
Why?
| Binding Sites | 4 | 2015 | 1247 | 0.050 |
Why?
| Laser Capture Microdissection | 1 | 2021 | 27 | 0.050 |
Why?
| Statistics, Nonparametric | 1 | 2003 | 416 | 0.050 |
Why?
| Histocompatibility Antigens | 1 | 2022 | 105 | 0.050 |
Why?
| Brain | 2 | 2013 | 2540 | 0.050 |
Why?
| Amino Acid Sequence | 3 | 2003 | 2123 | 0.050 |
Why?
| Mutation | 3 | 2021 | 3493 | 0.050 |
Why?
| Liver | 2 | 2006 | 1827 | 0.050 |
Why?
| Whole Genome Sequencing | 1 | 2021 | 114 | 0.050 |
Why?
| Histocompatibility Antigens Class I | 1 | 2022 | 176 | 0.050 |
Why?
| High-Throughput Nucleotide Sequencing | 2 | 2015 | 459 | 0.050 |
Why?
| Histocompatibility Antigens Class II | 1 | 2022 | 397 | 0.050 |
Why?
| Blotting, Western | 2 | 2016 | 1225 | 0.050 |
Why?
| Base Sequence | 2 | 2015 | 2186 | 0.050 |
Why?
| STAT1 Transcription Factor | 2 | 2011 | 68 | 0.050 |
Why?
| Chemokines | 2 | 2012 | 233 | 0.050 |
Why?
| Models, Genetic | 1 | 2003 | 599 | 0.040 |
Why?
| Tumor Necrosis Factor-alpha | 2 | 2016 | 1181 | 0.040 |
Why?
| Frameshift Mutation | 1 | 2019 | 28 | 0.040 |
Why?
| Breast Neoplasms | 2 | 2009 | 1994 | 0.040 |
Why?
| Enzyme-Linked Immunosorbent Assay | 2 | 2012 | 839 | 0.040 |
Why?
| Disease Models, Animal | 2 | 2021 | 3799 | 0.040 |
Why?
| Polymerase Chain Reaction | 1 | 2021 | 1021 | 0.040 |
Why?
| Promoter Regions, Genetic | 2 | 2015 | 1188 | 0.040 |
Why?
| Apoptosis | 3 | 2014 | 2532 | 0.040 |
Why?
| Haplotypes | 1 | 2019 | 482 | 0.040 |
Why?
| Cross-Linking Reagents | 1 | 1998 | 190 | 0.040 |
Why?
| Mutation, Missense | 1 | 2019 | 302 | 0.040 |
Why?
| Hypertrophy | 1 | 2017 | 125 | 0.040 |
Why?
| Jaw | 1 | 2017 | 19 | 0.040 |
Why?
| Pregnancy | 3 | 2006 | 5854 | 0.040 |
Why?
| Transduction, Genetic | 1 | 2017 | 118 | 0.040 |
Why?
| Nose | 1 | 2017 | 58 | 0.040 |
Why?
| Primary Cell Culture | 1 | 2017 | 156 | 0.040 |
Why?
| Tongue | 1 | 2017 | 74 | 0.040 |
Why?
| Genes, Reporter | 1 | 2017 | 274 | 0.040 |
Why?
| Adenoviridae | 1 | 2017 | 195 | 0.040 |
Why?
| Hypoxia | 1 | 2003 | 1003 | 0.040 |
Why?
| Autoradiography | 1 | 1996 | 73 | 0.040 |
Why?
| Acetic Acid | 1 | 1996 | 17 | 0.040 |
Why?
| Indicators and Reagents | 1 | 1996 | 102 | 0.030 |
Why?
| Acetates | 1 | 1996 | 100 | 0.030 |
Why?
| Electrophoretic Mobility Shift Assay | 1 | 2015 | 77 | 0.030 |
Why?
| Cell Proliferation | 2 | 2014 | 2328 | 0.030 |
Why?
| Exons | 2 | 2010 | 310 | 0.030 |
Why?
| Brain Neoplasms | 1 | 2003 | 1016 | 0.030 |
Why?
| Transforming Growth Factor beta | 1 | 2017 | 468 | 0.030 |
Why?
| Recombinant Fusion Proteins | 1 | 2017 | 661 | 0.030 |
Why?
| In Situ Hybridization | 1 | 2014 | 324 | 0.030 |
Why?
| Prognosis | 2 | 2012 | 3563 | 0.030 |
Why?
| RNA Interference | 1 | 2016 | 473 | 0.030 |
Why?
| Colorado | 1 | 2024 | 4325 | 0.030 |
Why?
| Bronchi | 1 | 2015 | 253 | 0.030 |
Why?
| Protein Kinase Inhibitors | 2 | 2010 | 833 | 0.030 |
Why?
| Enkephalins | 1 | 2013 | 13 | 0.030 |
Why?
| Male | 8 | 2013 | 59639 | 0.030 |
Why?
| Dopamine and cAMP-Regulated Phosphoprotein 32 | 1 | 2013 | 10 | 0.030 |
Why?
| Prealbumin | 1 | 2013 | 24 | 0.030 |
Why?
| Education | 1 | 2013 | 110 | 0.030 |
Why?
| Cytokines | 2 | 2012 | 1928 | 0.030 |
Why?
| Cartilage | 1 | 2014 | 196 | 0.030 |
Why?
| Myosins | 1 | 2013 | 130 | 0.030 |
Why?
| Cell Line, Tumor | 2 | 2010 | 2904 | 0.030 |
Why?
| RNA, Neoplasm | 1 | 2012 | 79 | 0.030 |
Why?
| Mice, Inbred Strains | 1 | 2013 | 418 | 0.030 |
Why?
| Middle Aged | 5 | 2012 | 28563 | 0.030 |
Why?
| Protein Precursors | 1 | 2013 | 126 | 0.030 |
Why?
| Lectins, C-Type | 1 | 2012 | 68 | 0.030 |
Why?
| Models, Molecular | 3 | 2003 | 1443 | 0.030 |
Why?
| Transcriptional Activation | 1 | 2014 | 360 | 0.030 |
Why?
| Protein Structure, Secondary | 2 | 2003 | 341 | 0.030 |
Why?
| Immunophenotyping | 1 | 2012 | 288 | 0.030 |
Why?
| DNA Mutational Analysis | 2 | 2003 | 390 | 0.030 |
Why?
| Alleles | 1 | 2014 | 852 | 0.030 |
Why?
| Exome | 1 | 2013 | 227 | 0.030 |
Why?
| Bone and Bones | 1 | 2014 | 296 | 0.030 |
Why?
| Glucocorticoids | 1 | 2016 | 554 | 0.030 |
Why?
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2010 | 11 | 0.020 |
Why?
| Genes, Neoplasm | 1 | 2010 | 22 | 0.020 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 346 | 0.020 |
Why?
| Disease-Free Survival | 1 | 2012 | 661 | 0.020 |
Why?
| Bronchoalveolar Lavage | 1 | 2010 | 98 | 0.020 |
Why?
| Tumor Suppressor Proteins | 1 | 2013 | 299 | 0.020 |
Why?
| Fibroblasts | 1 | 2015 | 846 | 0.020 |
Why?
| Neoplasm Invasiveness | 1 | 2012 | 472 | 0.020 |
Why?
| Imatinib Mesylate | 1 | 2010 | 63 | 0.020 |
Why?
| Molecular Sequence Annotation | 1 | 2010 | 91 | 0.020 |
Why?
| Caspases, Effector | 1 | 2010 | 2 | 0.020 |
Why?
| Dasatinib | 1 | 2010 | 48 | 0.020 |
Why?
| Surface-Active Agents | 1 | 2011 | 81 | 0.020 |
Why?
| Markov Chains | 1 | 2010 | 130 | 0.020 |
Why?
| Phagocytosis | 1 | 2012 | 368 | 0.020 |
Why?
| Principal Component Analysis | 1 | 2010 | 186 | 0.020 |
Why?
| Amino Acid Motifs | 2 | 2000 | 206 | 0.020 |
Why?
| Interferon Regulatory Factors | 1 | 2010 | 31 | 0.020 |
Why?
| ras Proteins | 1 | 2010 | 142 | 0.020 |
Why?
| Thiazoles | 1 | 2010 | 125 | 0.020 |
Why?
| Cyclosporine | 1 | 2010 | 175 | 0.020 |
Why?
| Benzamides | 1 | 2010 | 175 | 0.020 |
Why?
| Demography | 1 | 2010 | 290 | 0.020 |
Why?
| Amino Acid Substitution | 2 | 2000 | 278 | 0.020 |
Why?
| Quality Control | 1 | 2009 | 165 | 0.020 |
Why?
| Polymorphism, Genetic | 1 | 2013 | 666 | 0.020 |
Why?
| Inheritance Patterns | 1 | 2009 | 50 | 0.020 |
Why?
| Rats, Sprague-Dawley | 2 | 2006 | 2501 | 0.020 |
Why?
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2009 | 70 | 0.020 |
Why?
| Organ Specificity | 1 | 2009 | 287 | 0.020 |
Why?
| Genotype | 1 | 2014 | 1943 | 0.020 |
Why?
| RNA Splicing | 1 | 2010 | 250 | 0.020 |
Why?
| Embryo, Mammalian | 1 | 2009 | 222 | 0.020 |
Why?
| Interferons | 1 | 2010 | 154 | 0.020 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2011 | 358 | 0.020 |
Why?
| Blotting, Northern | 1 | 2008 | 199 | 0.020 |
Why?
| Perilipin-1 | 1 | 2008 | 16 | 0.020 |
Why?
| Tumor Cells, Cultured | 1 | 2010 | 904 | 0.020 |
Why?
| Estrogen Receptor Modulators | 1 | 2008 | 19 | 0.020 |
Why?
| Ethanol | 1 | 2013 | 584 | 0.020 |
Why?
| Kinetics | 1 | 2012 | 1658 | 0.020 |
Why?
| Neoplasm Staging | 1 | 2012 | 1234 | 0.020 |
Why?
| S100 Proteins | 1 | 2008 | 35 | 0.020 |
Why?
| Neoplasm Metastasis | 1 | 2010 | 563 | 0.020 |
Why?
| Cell Adhesion | 1 | 2009 | 454 | 0.020 |
Why?
| Bronchoalveolar Lavage Fluid | 1 | 2010 | 633 | 0.020 |
Why?
| Cell Communication | 1 | 2009 | 287 | 0.020 |
Why?
| RNA, Small Interfering | 1 | 2010 | 581 | 0.020 |
Why?
| Piperazines | 1 | 2010 | 326 | 0.020 |
Why?
| Adult | 4 | 2012 | 32385 | 0.020 |
Why?
| Biomedical Research | 1 | 2013 | 630 | 0.020 |
Why?
| Pyrimidines | 1 | 2010 | 388 | 0.020 |
Why?
| Tamoxifen | 1 | 2008 | 198 | 0.020 |
Why?
| Data Interpretation, Statistical | 1 | 2009 | 345 | 0.020 |
Why?
| Curriculum | 1 | 2013 | 925 | 0.020 |
Why?
| Cell Cycle | 1 | 2009 | 584 | 0.020 |
Why?
| Flow Cytometry | 1 | 2010 | 1128 | 0.020 |
Why?
| Phenotype | 1 | 2014 | 3070 | 0.020 |
Why?
| Immunosuppressive Agents | 1 | 2010 | 687 | 0.020 |
Why?
| Rats | 2 | 2006 | 5426 | 0.020 |
Why?
| Chromatin | 1 | 2009 | 450 | 0.020 |
Why?
| Extracellular Matrix | 1 | 2009 | 461 | 0.020 |
Why?
| Time Factors | 2 | 2009 | 6682 | 0.020 |
Why?
| Membrane Transport Proteins | 1 | 2006 | 137 | 0.020 |
Why?
| Genome-Wide Association Study | 1 | 2012 | 1376 | 0.020 |
Why?
| Phosphoproteins | 1 | 2008 | 332 | 0.020 |
Why?
| Quantitative Trait Loci | 1 | 2007 | 328 | 0.020 |
Why?
| Retrospective Studies | 1 | 2022 | 13433 | 0.020 |
Why?
| Receptors, Estrogen | 1 | 2008 | 388 | 0.020 |
Why?
| Research Design | 1 | 2011 | 1002 | 0.020 |
Why?
| Dietary Fats | 1 | 2006 | 325 | 0.020 |
Why?
| Carrier Proteins | 1 | 2008 | 740 | 0.010 |
Why?
| Sequence Analysis, Protein | 1 | 2003 | 30 | 0.010 |
Why?
| Immunohistochemistry | 1 | 2008 | 1727 | 0.010 |
Why?
| Milk Proteins | 1 | 2003 | 39 | 0.010 |
Why?
| Drug Resistance, Neoplasm | 1 | 2008 | 673 | 0.010 |
Why?
| Cell Differentiation | 1 | 2011 | 1805 | 0.010 |
Why?
| Stromal Cells | 1 | 2003 | 103 | 0.010 |
Why?
| Osteopontin | 1 | 2003 | 39 | 0.010 |
Why?
| Smoking | 1 | 2011 | 1556 | 0.010 |
Why?
| Corpus Callosum | 1 | 2003 | 57 | 0.010 |
Why?
| Sulfhydryl Reagents | 1 | 2002 | 11 | 0.010 |
Why?
| Sialoglycoproteins | 1 | 2003 | 162 | 0.010 |
Why?
| Temporal Arteries | 1 | 2003 | 47 | 0.010 |
Why?
| Disease Progression | 1 | 2010 | 2546 | 0.010 |
Why?
| Temporal Lobe | 1 | 2003 | 93 | 0.010 |
Why?
| Cohort Studies | 1 | 2012 | 5294 | 0.010 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2010 | 1402 | 0.010 |
Why?
| Reproducibility of Results | 1 | 2009 | 2977 | 0.010 |
Why?
| Frontal Lobe | 1 | 2003 | 152 | 0.010 |
Why?
| Plasmids | 1 | 2002 | 358 | 0.010 |
Why?
| Cysteine | 1 | 2002 | 187 | 0.010 |
Why?
| Structure-Activity Relationship | 1 | 2002 | 536 | 0.010 |
Why?
| Mice, Transgenic | 1 | 2006 | 2079 | 0.010 |
Why?
| Protein Structure, Tertiary | 1 | 2003 | 832 | 0.010 |
Why?
| Genetic Predisposition to Disease | 1 | 2009 | 2359 | 0.010 |
Why?
| Serine | 1 | 2000 | 142 | 0.010 |
Why?
| Conserved Sequence | 1 | 2000 | 220 | 0.010 |
Why?
| Cyclic AMP | 1 | 2000 | 260 | 0.010 |
Why?
| Tyrosine | 1 | 2000 | 267 | 0.010 |
Why?
| Lipids | 1 | 2003 | 614 | 0.010 |
Why?
| Aged, 80 and over | 1 | 2011 | 6845 | 0.010 |
Why?
| Gene Deletion | 1 | 2000 | 365 | 0.010 |
Why?
| Aged | 2 | 2011 | 20495 | 0.010 |
Why?
| Escherichia coli | 1 | 2002 | 767 | 0.010 |
Why?
| Protein Conformation | 1 | 2000 | 851 | 0.010 |
Why?
| Pulmonary Artery | 1 | 2003 | 1097 | 0.010 |
Why?
| Antibodies | 1 | 1998 | 400 | 0.010 |
Why?
| Young Adult | 1 | 2010 | 11094 | 0.010 |
Why?
| Hypertension, Pulmonary | 1 | 2003 | 1900 | 0.010 |
Why?
| Adolescent | 1 | 2003 | 18948 | 0.000 |
Why?
| Child | 1 | 2003 | 19561 | 0.000 |
Why?
|
|
Phang's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|